Key result
Thoracic endovascular aortic repair (TEVAR) is an effective strategy for complicated acute type B aortic dissection, associated with low operative mortality and morbidity.
Why the study?
Does thoracic endovascular aortic repair (TEVAR) improve outcomes in patients with acute type B aortic dissection?
Does thoracic endovascular aortic repair (TEVAR) improve outcomes in patients with acute type B aortic dissection?
TEVAR is an effective strategy for acute type B aortic dissection, with expanding indications including retrograde type A dissection.
Answers are grounded in this paper and cite their sources.
May support TEVAR in complicated acute type B dissection; leaves open phase-specific timing and prospective validation.
The rationale for thoracic endovascular aortic repair (TEVAR) for type B aortic dissection depends on the phase of disease: acute phase, which is ‘complicated’, subacute to early chronic phase, which requires ‘preemptive TEVAR’ and chronic phase, which entails ‘prevention of further dilatation and rupture’. Low operative mortality and morbidity after TEVAR for complicated acute type B aortic dissection have been reported with significant improvement during midterm survival. ‘Retrograde’ type A dissection, which can be described as type B 0,X (X>3) according to a new reporting standard, has reportedly been treated with TEVAR with less invasiveness. TEVAR is the first and possibly the only effective strategy for acute type B dissection, so that expansion of indications for type B 0,X , as described in the new reporting standard has been validated.
No takes yet. Share an insight, caveat, or question.
Hitoshi Matsuda (2022) conducted a review in Acute type B aortic dissection. Thoracic endovascular aortic repair (TEVAR) was evaluated. Thoracic endovascular aortic repair (TEVAR) is an effective strategy for complicated acute type B aortic dissection, associated with low operative mortality and morbidity.
Synapse has enriched 10 related papers. Consider them for comparative context: